RS
Raunak Shrivastava
About Raunak Shrivastava
Data last updated:
Raunak Shrivastava is a Designated Partner at Emarlex Multiventure Llp (since 2021). The companies operate in Business Services. Earlier, Raunak Shrivastava was a Director at Med Asia Drugs & Pharmaceuticals Private Limited (2020–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 08 Nov 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Mar 2020 | 2020 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Raunak Shrivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Kumar Shrivastava | 09389639 | Emarlex Multiventure Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raunak Shrivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raunak Shrivastava
Raunak Shrivastava currently holds 1 directorship: Emarlex Multiventure Llp (Designated Partner, since 08 Nov 2021).
Raunak Shrivastava was first appointed on 20 Mar 2020 as Director at Med Asia Drugs & Pharmaceuticals Private Limited. The most recent appointment on record is 08 Nov 2021 at Emarlex Multiventure Llp.
Raunak Shrivastava held 1 earlier board appointment: Med Asia Drugs & Pharmaceuticals Private Limited (Director, 20 Mar 2020 to 29 Sep 2021).
The current boards of Raunak Shrivastava's companies include Anil Kumar Shrivastava (Emarlex Multiventure Llp).